Last reviewed · How we verify
Aspirin Migraine
At a glance
| Generic name | Aspirin Migraine |
|---|---|
| Sponsor | Bayer |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Quality Improvement and Practice Based Research in Neurology Using the EMR (PHASE4)
- Effect of Manual Therapy on Migraine in Postmenopausal Women (NA)
- Assessment of Oral Caffeine Intake in Changing the Severity of Acute Migraine Attack Using VAS Score Among Patients Attending Headache and Neurology Outpatients Clinic of Ainshams University Hospitals (PHASE4)
- Effectivity and Safety of PFO Closure vs Medicine in Alleviating Migraine (PHASE3)
- pLatelEts And MigRaine iN patEnt foRamen Ovale (NA)
- Comparison of the Effect of Medication Therapy in Alleviating Migraine With Patent Foramen Ovale (PHASE4)
- COMParison of the EffecT of dEvice Closure in Alleviating Migraine With PFO (COMPETE-2) (PHASE4)
- Prochlorperazine Versus Acetaminophen, Aspirin, and Caffeine for the Treatment of Acute Migraine (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Aspirin Migraine CI brief — competitive landscape report
- Aspirin Migraine updates RSS · CI watch RSS
- Bayer portfolio CI